{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:46:01Z","timestamp":1764020761893,"version":"3.32.0"},"reference-count":83,"publisher":"American Association for Laboratory Animal Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>Disturbances in gut microbiota are prevalent in inflammatory bowel disease (IBD), which includes ulcerative colitis (UC). However, whether these disturbances contribute to development of the disease or are a result of the disease is unclear. In pairs of human twins discordant for IBD, the healthy twin has a higher risk of developing IBD and a gut microbiota that is more similar to that of IBD patients as compared with healthy individuals. Furthermore, appropriate medical treatment may mitigate these disturbances. To study the correlation between microbiota and IBD, we transferred stool samples from a discordant human twin pair: one twin being healthy and the other receiving treatment for UC. The stool samples were transferred from the disease-discordant twins to germ-free pregnant dams. Colitis was induced in the offspring using dextran sodium sulfate. As compared with offspring born to mice dams inoculated with stool from the healthy cotwin, offspring born to dams inoculated with stool from the UC-afflicted twin had a lower disease activity index, less gut inflammation, and a microbiota characterized by higher \u03b1 diversity and a more antiinflammatory profile that included the presence and higher abundance of antiinflammatory species such as <jats:italic>Akkermansia<\/jats:italic> spp., <jats:italic>Bacteroides<\/jats:italic> spp., and <jats:italic>Parabacteroides<\/jats:italic> spp. These findings suggest that the microbiota from the healthy twin may have had greater inflammatory properties than did that of the twin undergoing UC treatment.<\/jats:p>","DOI":"10.30802\/aalas-cm-23-000065","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T01:06:56Z","timestamp":1710983216000},"page":"55-69","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of the Inflammatory Effects of Gut Microbiota from Human Twins Discordant for Ulcerative Colitis on Germ-free Mice"],"prefix":"10.30802","volume":"74","author":[{"given":"Lina A","family":"Knudsen","sequence":"first","affiliation":[{"name":"Medical Department, Molecular Diagnostic and Clinical Research, University Hospital of Southern Denmark, Aabenraa, Denmark;"},{"name":"IRS-Center Sonderjylland, University of Southern Denmark, Odense, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line SF","family":"Zachariassen","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael L","family":"Strube","sequence":"additional","affiliation":[{"name":"DTU Bioengineering, Technical University of Denmark, Lyngby, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper F","family":"Havelund","sequence":"additional","affiliation":[{"name":"VILLUM Center for Bioanalytical Sciences, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Pilecki","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders B","family":"Nexoe","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik T","family":"M\u00f8ller","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe B","family":"S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Medical Department, Molecular Diagnostic and Clinical Research, University Hospital of Southern Denmark, Aabenraa, Denmark;"},{"name":"Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Marcussen","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Odense University Hospital, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils J","family":"F\u00e6rgeman","sequence":"additional","affiliation":[{"name":"VILLUM Center for Bioanalytical Sciences, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Franke","sequence":"additional","affiliation":[{"name":"Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Bang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uffe","family":"Holmskov","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel K","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"Andersen","sequence":"additional","affiliation":[{"name":"Medical Department, Molecular Diagnostic and Clinical Research, University Hospital of Southern Denmark, Aabenraa, Denmark;"},{"name":"IRS-Center Sonderjylland, University of Southern Denmark, Odense, Denmark;"},{"name":"Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12258","reference":[{"key":"bib1","series-title":"Gut Pathog","first-page":"1","article-title":"Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels","volume":"12","author":"AlamMT","year":"2020","unstructured":"AlamMT, AmosGCA, MurphyARJ, MurchS, WellingtonEMH, ArasaradnamRP. 2020. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels. Gut Pathog 12:1. https:\/\/doi.org\/10.1186\/s13099-019-0341-6."},{"key":"bib2","series-title":"Nat Rev Gastroenterol Hepatol","first-page":"205","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"AnanthakrishnanAN","year":"2015","unstructured":"AnanthakrishnanAN. 2015. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12:205\u2013217. https:\/\/doi.org\/10.1038\/nrgastro.2015.34."},{"key":"bib3","series-title":"Nutrients","first-page":"326","article-title":"Potential impact of diet on treatment effect from anti-tnf drugs in inflammatory bowel disease","volume":"9","author":"AndersenV","year":"2017","unstructured":"AndersenV, HansenAK, HeitmannBL. 2017. Potential impact of diet on treatment effect from anti-tnf drugs in inflammatory bowel disease. Nutrients 9:326. https:\/\/doi.org\/10.3390\/nu9030286."},{"key":"bib4","series-title":"Microorganisms","first-page":"697","article-title":"The role of Enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases","volume":"9","author":"BaldelliV","year":"2021","unstructured":"BaldelliV, ScaldaferriF, PutignaniL, Del ChiericoF. 2021. The role of Enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases. Microorganisms 9:697. https:\/\/doi.org\/10.3390\/microorganisms9040697."},{"key":"bib5","series-title":"Inflamm Bowel Dis","first-page":"347","article-title":"Human gut microbiome transplantation in ileitis prone mice: A tool for the functional characterization of the microbiota in inflammatory bowel disease patients","volume":"26","author":"BassonAR","year":"2020","unstructured":"BassonAR, Gomez-NguyenA, MenghiniP, Butt\u00f3LF, Di MartinoL, AladyshkinaN, OsmeA. 2020. Human gut microbiome transplantation in ileitis prone mice: A tool for the functional characterization of the microbiota in inflammatory bowel disease patients. Inflamm Bowel Dis 26:347\u2013359."},{"key":"bib6","series-title":"ISME J","first-page":"1449","article-title":"Microbes inside\u2013From diversity to function: The case of Akkermansia","volume":"6","author":"BelzerC","year":"2012","unstructured":"BelzerC, de VosWM. 2012. Microbes inside\u2013From diversity to function: The case of Akkermansia. ISME J 6:1449\u20131458. https:\/\/doi.org\/10.1038\/ismej.2012.6."},{"key":"bib7","series-title":"PLoS One","first-page":"e0176662","article-title":"Immunological effects of reduced mucosal integrity in the early life of BALB\/c mice","volume":"12","author":"BendtsenKM","year":"2017","unstructured":"BendtsenKM, HansenCHF, KrychL, SkovgaardK, KotW, VogensenFK, HansenAK. 2017. Immunological effects of reduced mucosal integrity in the early life of BALB\/c mice. PLoS One 12:e0176662. https:\/\/doi.org\/10.1371\/journal.pone.0176662."},{"key":"bib8","series-title":"Inflammation","first-page":"1437","article-title":"An early life mucosal insult temporarily decreases acute oxazolone-induced inflammation in mice","volume":"41","author":"BendtsenKM","year":"2018","unstructured":"BendtsenKM, TougaardP, HansenAK. 2018. An early life mucosal insult temporarily decreases acute oxazolone-induced inflammation in mice. Inflammation 41:1437\u20131447. https:\/\/doi.org\/10.1007\/s10753-018-0790-y."},{"key":"bib9","series-title":"Cancer Epidemiol Biomarkers Prev","first-page":"1004","article-title":"Standard preanalytical coding for biospecimens: Defining the sample PREanalytical code","volume":"19","author":"BetsouF","year":"2010","unstructured":"BetsouF, LehmannS, AshtonG, BarnesM, BensonEE, CoppolaD, DeSouzaY. 2010. Standard preanalytical coding for biospecimens: Defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev 19:1004\u20131011. https:\/\/doi.org\/10.1158\/1055-9965.EPI-09-1268."},{"key":"bib10","series-title":"Mamm Genome","first-page":"865","article-title":"Refined histopathologic scoring system improves power to detect colitis QTL in mice","volume":"15","author":"BleichA","year":"2004","unstructured":"BleichA, M\u00e4hlerM, MostC, LeiterEH, Liebler\u2013TenorioE, ElsonCO, HedrichHJ, SchlegelbergerB, SundbergJP. 2004. Refined histopathologic scoring system improves power to detect colitis QTL in mice. Mamm Genome 15:865\u2013871. https:\/\/doi.org\/10.1007\/s00335-004-2392-2."},{"key":"bib11","series-title":"Gastroenterology","first-page":"1970","article-title":"Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients","volume":"160","author":"BrandEC","year":"2021","unstructured":"BrandEC, KlaassenMAY, GacesaR, Vich VilaA, GhoshH, de ZoeteMR, BoomsmaDI. 2021. Healthy cotwins share gut microbiome signatures with their inflammatory bowel disease twins and unrelated patients. Gastroenterology 160:1970\u20131985. https:\/\/doi.org\/10.1053\/j.gastro.2021.01.030."},{"key":"bib12","series-title":"Immunity","first-page":"212","article-title":"Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORgammat(+) regulatory T cells and exacerbate colitis in mice","volume":"50","author":"BrittonGJ","year":"2019","unstructured":"BrittonGJ, ContijochEJ, MognoI, VennaroOH, LlewellynSR, NgR, LiZ. 2019. Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORgammat(+) regulatory T cells and exacerbate colitis in mice. Immunity 50:212\u2013224.e214. https:\/\/doi.org\/10.1016\/j.immuni.2018.12.015."},{"key":"bib13","series-title":"J Biol Chem","first-page":"11312","article-title":"The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids","volume":"278","author":"BrownAJ","year":"2003","unstructured":"BrownAJ, GoldsworthySM, BarnesAA, EilertMM, TcheangL, DanielsD, MuirAI. 2003. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278:11312\u201311319. https:\/\/doi.org\/10.1074\/jbc.M211609200."},{"key":"bib14","series-title":"World J Gastrointest Surg","first-page":"193","article-title":"Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases","volume":"8","author":"CaccaroR","year":"2016","unstructured":"CaccaroR, AngrimanI, D\u2019Inc\u00e0R. 2016. Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases. World J Gastrointest Surg 8:193\u2013201. https:\/\/doi.org\/10.4240\/wjgs.v8.i3.193."},{"key":"bib15","series-title":"Nutrients","first-page":"1067","article-title":"Food and food groups in inflammatory bowel disease (IBD): The design of the groningen anti-inflammatory diet (GrAID)","volume":"13","author":"Campmans-KuijpersMJE","year":"2021","unstructured":"Campmans-KuijpersMJE, DijkstraG. 2021. Food and food groups in inflammatory bowel disease (IBD): The design of the groningen anti-inflammatory diet (GrAID). Nutrients 13:1067. https:\/\/doi.org\/10.3390\/nu13041067."},{"year":"2021","key":"bib16","unstructured":"Centers for Disease Control and Prevention. [Internet]. 2021. Defining adult overweight & obesity. [Cited 9 March 2024]. Available at: https:\/\/www.cdc.gov\/obesity\/adult\/basics\/defining.html."},{"key":"bib17","series-title":"N Engl J Med","first-page":"2652","article-title":"Pathophysiology of inflammatory bowel diseases","volume":"383","author":"ChangJT","year":"2020","unstructured":"ChangJT. 2020. Pathophysiology of inflammatory bowel diseases. N Engl J Med 383:2652\u20132664. https:\/\/doi.org\/10.1056\/NEJMra2002697."},{"issue":"W1","key":"bib18","series-title":"Nucleic Acids Res","first-page":"W486","article-title":"MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis","volume":"46","author":"ChongJ","year":"2018","unstructured":"ChongJ, SoufanO, LiC, CarausI, LiS, BourqueG, WishartDS, XiaJ. 2018. MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis. Nucleic Acids Res 46W1W486\u2013W494. https:\/\/doi.org\/10.1093\/nar\/gky310."},{"key":"bib19","series-title":"Cell","first-page":"1578","article-title":"Gut immune maturation depends on colonization with a host-specific microbiota","volume":"149","author":"ChungH","year":"2012","unstructured":"ChungH, PampSJ, HillJA, SuranaNK, EdelmanSM, TroyEB, ReadingNC. 2012. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149:1578\u20131593. https:\/\/doi.org\/10.1016\/j.cell.2012.04.037."},{"key":"bib20","series-title":"J Crohn\u2019s Colitis","first-page":"307","article-title":"Gut microbiota-driven drug metabolism in inflammatory bowel disease","volume":"15","author":"CrouwelF","year":"2021","unstructured":"CrouwelF, BuiterHJC, de BoerNK. 2021. Gut microbiota-driven drug metabolism in inflammatory bowel disease. J Crohn\u2019s Colitis 15:307\u2013315. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa143."},{"key":"bib21","series-title":"Front Microbiol","first-page":"166","article-title":"Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila","volume":"2","author":"DerrienM","year":"2011","unstructured":"DerrienM, Van BaarlenP, HooiveldG, NorinE, MullerM, de VosWM. 2011. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol 2:166. https:\/\/doi.org\/10.3389\/fmicb.2011.00166."},{"key":"bib22","series-title":"Lancet Gastroenterol Hepatol","first-page":"17","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","unstructured":"GBD 2017 Inflammatory Bowel Disease Collaborators. 2020. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5:17\u201330. https:\/\/doi.org\/10.1016\/S2468-1253(19)30333-4."},{"key":"bib23","series-title":"Proc Natl Acad Sci USA","first-page":"6252","article-title":"Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice","volume":"108","author":"GoodmanAL","year":"2011","unstructured":"GoodmanAL, KallstromG, FaithJJ, ReyesA, MooreA, DantasG, GordonJI. 2011. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci USA 108:6252\u20136257. https:\/\/doi.org\/10.1073\/pnas.1102938108."},{"key":"bib24","series-title":"Inflamm Bowel Dis","first-page":"1428","article-title":"Heritability in inflammatory bowel disease: From the first twin study to genome-wide association studies","volume":"21","author":"GordonH","year":"2015","unstructured":"GordonH, Trier MollerF, AndersenV, HarbordM. 2015. Heritability in inflammatory bowel disease: From the first twin study to genome-wide association studies. Inflamm Bowel Dis 21:1428\u20131434. https:\/\/doi.org\/10.1097\/MIB.0000000000000393."},{"key":"bib25","series-title":"Gut","first-page":"1445","article-title":"Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice","volume":"67","author":"HanninenA","year":"2018","unstructured":"HanninenA, ToivonenR, PoystiS, BelzerC, PlovierH, OuwerkerkJP, EmaniR. 2018. Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut 67:1445\u20131453. https:\/\/doi.org\/10.1136\/gutjnl-2017-314508."},{"key":"bib26","series-title":"Lab Anim","first-page":"281","article-title":"Bacterial species to be considered in quality assurance of mice and rats","volume":"53","author":"HansenAK","year":"2019","unstructured":"HansenAK, NielsenDS, KrychL, HansenCHF. 2019. Bacterial species to be considered in quality assurance of mice and rats. Lab Anim 53:281\u2013291. https:\/\/doi.org\/10.1177\/0023677219834324."},{"key":"bib27","series-title":"Diabetologia","first-page":"2285","article-title":"Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse","volume":"55","author":"HansenCH","year":"2012","unstructured":"HansenCH, KrychL, NielsenDS, VogensenFK, HansenLH, SorensenSJ, BuschardK. 2012. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55:2285\u20132294. https:\/\/doi.org\/10.1007\/s00125-012-2564-7."},{"key":"bib28","series-title":"J Neurochem","first-page":"756","article-title":"Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia","volume":"142","author":"HavelundJF","year":"2017","unstructured":"HavelundJF, AndersenAD, BinzerM, BlaabjergM, HeegaardNHH, StenagerE, FaergemanNJ. 2017. Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia. J Neurochem 142:756\u2013766. https:\/\/doi.org\/10.1111\/jnc.14104."},{"key":"bib29","series-title":"Int Immunopharmacol","first-page":"137","article-title":"Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice","volume":"21","author":"HolgersenK","year":"2014","unstructured":"HolgersenK, KvistPH, HansenAK, HolmTL. 2014. Predictive validity and immune cell involvement in the pathogenesis of piroxicam-accelerated colitis in interleukin-10 knockout mice. Int Immunopharmacol 21:137\u2013147. https:\/\/doi.org\/10.1016\/j.intimp.2014.04.017."},{"key":"bib30","series-title":"Inflamm Bowel Dis","first-page":"963","article-title":"Using corticosteroids to reshape the gut microbiome: Implications for inflammatory bowel diseases","volume":"21","author":"HuangEY","year":"2015","unstructured":"HuangEY, InoueT, LeoneVA, DalalS, TouwK, WangY, MuschMW. 2015. Using corticosteroids to reshape the gut microbiome: Implications for inflammatory bowel diseases. Inflamm Bowel Dis 21:963\u2013972. https:\/\/doi.org\/10.1097\/MIB.0000000000000332."},{"key":"bib31","series-title":"Nutrients","first-page":"890","article-title":"Therapeutic implications of diet in inflammatory bowel disease and related immune-mediated inflammatory diseases","volume":"13","author":"JiangY","year":"2021","unstructured":"JiangY, JarrK, LaytonC, GardnerCD, AshouriJF, AbreuMT, SinhaSR. 2021. Therapeutic implications of diet in inflammatory bowel disease and related immune-mediated inflammatory diseases. Nutrients 13:890. https:\/\/doi.org\/10.3390\/nu13030890."},{"year":"2021","author":"KhangX","key":"bib32","unstructured":"KhangX, JiaM, ZhaoL, ZhangS. [Internet]. 2021. 2.2.1. Disease activity index (DAI). [Cited 9 March 2024]. Available at: https:\/\/bio-protocol.org\/exchange\/minidetail?type=30&id=9164061."},{"key":"bib33","series-title":"Nat Rev Dis Primers","first-page":"74","article-title":"Ulcerative colitis","volume":"6","author":"KobayashiT","year":"2020","unstructured":"KobayashiT, SiegmundB, Le BerreC, WeiSC, FerranteM, ShenB, BernsteinCN, DaneseS, Peyrin-BirouletL, HibiT. 2020. Ulcerative colitis. Nat Rev Dis Primers 6:74. https:\/\/doi.org\/10.1038\/s41572-020-0205-x."},{"key":"bib34","series-title":"Clin Exp Immunol","first-page":"250","article-title":"Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition","volume":"163","author":"KverkaM","year":"2011","unstructured":"KverkaM, ZakostelskaZ, KlimesovaK, SokolD, HudcovicT, HrncirT, RossmannP. 2011. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 163:250\u2013259. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04286.x."},{"key":"bib35","series-title":"Gut","first-page":"1739","article-title":"New IBD genetics: Common pathways with other diseases","volume":"60","author":"LeesCW","year":"2011","unstructured":"LeesCW, BarrettJC, ParkesM, SatsangiJ. 2011. New IBD genetics: Common pathways with other diseases. Gut 60:1739\u20131753. https:\/\/doi.org\/10.1136\/gut.2009.199679."},{"key":"bib36","series-title":"Gut","first-page":"1031","article-title":"The effect of heritability and host genetics on the gut microbiota and metabolic syndrome","volume":"66","author":"LimMY","year":"2017","unstructured":"LimMY, YouHJ, YoonHS, KwonB, LeeJY, LeeS, SongYM, LeeK, SungJ, KoG. 2017. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut 66:1031\u20131038. https:\/\/doi.org\/10.1136\/gutjnl-2015-311326."},{"key":"bib37","series-title":"Front Microbiol","first-page":"527","article-title":"Azathioprine, mercaptopurine, and 5-aminosalicylic acid affect the growth of IBD-associated Campylobacter species and other enteric microbes","volume":"8","author":"LiuF","year":"2017","unstructured":"LiuF, MaR, RiordanSM, GrimmMC, LiuL, WangY, ZhangL. 2017. Azathioprine, mercaptopurine, and 5-aminosalicylic acid affect the growth of IBD-associated Campylobacter species and other enteric microbes. Front Microbiol 8:527. https:\/\/doi.org\/10.3389\/fmicb.2017.00527."},{"key":"bib38","series-title":"ISME J","first-page":"841","article-title":"Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics","volume":"11","author":"Lopez-SilesM","year":"2017","unstructured":"Lopez-SilesM, DuncanSH, Garcia-GilLJ, Martinez-MedinaM. 2017. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J 11:841\u2013852. https:\/\/doi.org\/10.1038\/ismej.2016.176."},{"key":"bib39","series-title":"Environ Health Perspect","first-page":"284","article-title":"Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: An integrated metagenomics and metabolomics analysis","volume":"122","author":"LuK","year":"2014","unstructured":"LuK, AboRP, SchlieperKA, GraffamME, LevineS, WishnokJS, SwenbergJA, TannenbaumSR, FoxJG. 2014. Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: An integrated metagenomics and metabolomics analysis. Environ Health Perspect 122:284\u2013291. https:\/\/doi.org\/10.1289\/ehp.1307429."},{"key":"bib40","series-title":"Sci Rep","first-page":"42245","article-title":"Microbiota composition of simultaneously colonized mice housed under either a gnotobiotic isolator or individually ventilated cage regime","volume":"7","author":"LundbergR","year":"2017","unstructured":"LundbergR, BahlMI, LichtTR, ToftMF, HansenAK. 2017. Microbiota composition of simultaneously colonized mice housed under either a gnotobiotic isolator or individually ventilated cage regime. Sci Rep 7:42245. https:\/\/doi.org\/10.1038\/srep42245."},{"key":"bib41","series-title":"Sci Rep","first-page":"7805","article-title":"Human microbiota-transplanted C57BL\/6 mice and offspring display reduced establishment of key bacteria and reduced immune stimulation compared to mouse microbiota-transplantation","volume":"10","author":"LundbergR","year":"2020","unstructured":"LundbergR, ToftMF, MetzdorffSB, HansenCHF, LichtTR, BahlMI, HansenAK. 2020. Human microbiota-transplanted C57BL\/6 mice and offspring display reduced establishment of key bacteria and reduced immune stimulation compared to mouse microbiota-transplantation. Sci Rep 10:7805. https:\/\/doi.org\/10.1038\/s41598-020-64703-z."},{"key":"bib42","series-title":"J Crohns Colitis","first-page":"943","article-title":"Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota composition","volume":"10","author":"MagnussonMK","year":"2016","unstructured":"MagnussonMK, StridH, SapnaraM, LassonA, BajorA, UngKA, OhmanL. 2016. Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota composition. J Crohns Colitis 10:943\u2013952. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw051."},{"key":"bib43","series-title":"Lab Anim","first-page":"178","article-title":"FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units","volume":"48","author":"Mahler ConvenorM","year":"2014","unstructured":"Mahler ConvenorM, BerardM, FeinsteinR, GallagherA, Illgen-WilckeB, Pritchett-CorningK, RaspaM. 2014. FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim 48:178\u2013192. https:\/\/doi.org\/10.1177\/0023677213516312."},{"key":"bib44","series-title":"Nutrients","first-page":"12","article-title":"Nutrition, IBD and gut microbiota: A review","volume":"12","author":"MentellaMC","year":"2020","unstructured":"MentellaMC, ScaldaferriF, PizzoferratoM, GasbarriniA, MiggianoGAD. 2020. Nutrition, IBD and gut microbiota: A review. Nutrients 12:12. https:\/\/doi.org\/10.3390\/nu12040944."},{"key":"bib45","series-title":"Inflammation","first-page":"225","article-title":"The effect of selected amino acids on gelatin-induced inflammation in adult male mice","volume":"3","author":"MeyersBE","year":"1979","unstructured":"MeyersBE, MoonkaDK, DavisRH. 1979. The effect of selected amino acids on gelatin-induced inflammation in adult male mice. Inflammation 3:225\u2013233. https:\/\/doi.org\/10.1007\/BF00914179."},{"key":"bib46","series-title":"Nat Microbiol","first-page":"262","article-title":"Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity","volume":"7","author":"MillsRH","year":"2022","unstructured":"MillsRH, DulaiPS, V\u00e1zquez-BaezaY, SaucedaC, DanielN, GernerRR, BatachariLE. 2022. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nat Microbiol 7:262\u2013276. https:\/\/doi.org\/10.1038\/s41564-021-01050-3."},{"key":"bib47","series-title":"W J Gastroenterlo","first-page":"5050","article-title":"Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity","volume":"22","author":"MollerFT","year":"2016","unstructured":"MollerFT, KnudsenL, HarbordM, SatsangiJ, GordonH, ChristiansenL, ChristensenK, JessT, AndersenV. 2016. Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity. W J Gastroenterlo 22:5050\u20135059. https:\/\/doi.org\/10.3748\/wjg.v22.i21.5050."},{"key":"bib48","series-title":"Int J Inflam","first-page":"2859135","article-title":"Natural products with Toll-like receptor 4 antagonist activity","volume":"2018","author":"MolteniM","year":"2018","unstructured":"MolteniM, BosiA, RossettiC. 2018. Natural products with Toll-like receptor 4 antagonist activity. Int J Inflam 2018:2859135. https:\/\/doi.org\/10.1155\/2018\/2859135."},{"key":"bib49","series-title":"Biopreserv Biobank","first-page":"57","article-title":"Biospecimen reporting for improved study quality","volume":"9","author":"MooreHM","year":"2011","unstructured":"MooreHM, KellyA, JewellSD, McShaneLM, ClarkDP, GreenspanR, HainautP. 2011. Biospecimen reporting for improved study quality. Biopreserv Biobank 9:57\u201370. https:\/\/doi.org\/10.1089\/bio.2010.0036."},{"key":"bib50","series-title":"Cell Host Microbe","first-page":"362","article-title":"Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation","volume":"29","author":"NayakRR","year":"2021","unstructured":"NayakRR, AlexanderM, DeshpandeI, Stapleton-GrayK, RimalB, PattersonAD, UbedaC. 2021. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation. Cell Host Microbe 29:362\u2013377.e311. https:\/\/doi.org\/10.1016\/j.chom.2020.12.008."},{"key":"bib51","series-title":"Clin J Gastroenterol","first-page":"1","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"NishidaA","year":"2018","unstructured":"NishidaA, InoueR, InatomiO, BambaS, NaitoY, AndohA. 2018. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol 11:1\u201310. https:\/\/doi.org\/10.1007\/s12328-017-0813-5."},{"author":"OksanenJ","key":"bib52","unstructured":"OksanenJ, BlanchetFG, FriendlyM, KindtR, LegendreP, McGlinnD, MinchinPR [Internet]. Vegan: Community ecology package. R package version 2.5-4. [Cited 9 March 2024]. Available at: https:\/\/CRAN.R-project.org\/package=vegan."},{"key":"bib53","series-title":"Best Pract Res Clin Gastroenterol","first-page":"637","article-title":"Action and function of Akkermansia muciniphila in microbiome ecology, health and disease","volume":"31","author":"OttmanN","year":"2017","unstructured":"OttmanN, GeerlingsSY, AalvinkS, de VosWM, BelzerC. 2017. Action and function of Akkermansia muciniphila in microbiome ecology, health and disease. Best Pract Res Clin Gastroenterol 31:637\u2013642. https:\/\/doi.org\/10.1016\/j.bpg.2017.10.001."},{"key":"bib54","series-title":"Clin Biochem Rev","first-page":"77","article-title":"Faecal calprotectin","volume":"39","author":"PathiranaWGW","year":"2018","unstructured":"PathiranaWGW, ChubbSP, GillettMJ, VasikaranSD. 2018. Faecal calprotectin. Clin Biochem Rev 39:77\u201390.."},{"year":"2017","key":"bib55","unstructured":"Order on the Animal Experimentation Act. [Internet]. 2017. LBK 1107 of July 1, 2022. [Cited 9 March 2024]. Available at: https:\/\/www.retsinformation.dk\/eli\/lta\/2022\/1107."},{"key":"bib56","series-title":"PLoS Biol","first-page":"e3000410","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du SertN","year":"2020","unstructured":"Percie du SertN, HurstV, AhluwaliaA, AlamS, AveyMT, BakerM, BrowneWJ. 2020. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol 18:e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410."},{"key":"bib57","series-title":"BMC Bioinformatics","first-page":"395","article-title":"MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data","volume":"11","author":"PluskalT","year":"2010","unstructured":"PluskalT, CastilloS, Villar-BrionesA, OresicM. 2010. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 11:395. https:\/\/doi.org\/10.1186\/1471-2105-11-395."},{"key":"bib58","series-title":"Am J Gastroenterol","first-page":"2420","article-title":"Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria","volume":"105","author":"PngCW","year":"2010","unstructured":"PngCW, LindenSK, GilshenanKS, ZoetendalEG, McSweeneyCS, SlyLI, McGuckinMA. 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 105:2420\u20132428. https:\/\/doi.org\/10.1038\/ajg.2010.281."},{"key":"bib59","series-title":"Gut","first-page":"2122","article-title":"Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model","volume":"69","author":"RasmussenTS","year":"2020","unstructured":"RasmussenTS, MentzelCMJ, KotW, Castro-MejiaJL, ZuffaS, SwannJR, HansenLH. 2020. Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model. Gut 69:2122\u20132130. https:\/\/doi.org\/10.1136\/gutjnl-2019-320005."},{"key":"bib60","series-title":"Science","first-page":"1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"RidauraVK","year":"2013","unstructured":"RidauraVK, FaithJJ, ReyFE, ChengJ, DuncanAE, KauAL, GriffinNW. 2013. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341:1241214. https:\/\/doi.org\/10.1126\/science.1241214."},{"key":"bib61","series-title":"Proc Natl Acad Sci USA","first-page":"12204","article-title":"Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota","volume":"107","author":"RoundJL","year":"2010","unstructured":"RoundJL, MazmanianSK. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 107:12204\u201312209. https:\/\/doi.org\/10.1073\/pnas.0909122107."},{"key":"bib62","series-title":"Gigascience","first-page":"13","article-title":"The role of reporting standards for metabolite annotation and identification in metabolomic studies","volume":"2","author":"SalekRM","year":"2013","unstructured":"SalekRM, SteinbeckC, ViantMR, GoodacreR, DunnWB. 2013. The role of reporting standards for metabolite annotation and identification in metabolomic studies. Gigascience 2:13. https:\/\/doi.org\/10.1186\/2047-217X-2-13."},{"key":"bib63","series-title":"Gastroenterology","first-page":"577","article-title":"Microbial influences in inflammatory bowel diseases","volume":"134","author":"SartorRB","year":"2008","unstructured":"SartorRB. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577\u2013594. https:\/\/doi.org\/10.1053\/j.gastro.2007.11.059."},{"key":"bib64","series-title":"Gastroenterology","first-page":"327","article-title":"Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches","volume":"152","author":"SartorRB","year":"2017","unstructured":"SartorRB, WuGD. 2017. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology 152:327\u2013339.4. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.012."},{"key":"bib65","series-title":"J Gastroenterol","first-page":"495","article-title":"The microbiota in inflammatory bowel disease","volume":"50","author":"SheehanD","year":"2015","unstructured":"SheehanD, MoranC, ShanahanF. 2015. The microbiota in inflammatory bowel disease. J Gastroenterol 50:495\u2013507. https:\/\/doi.org\/10.1007\/s00535-015-1064-1."},{"key":"bib66","series-title":"Lab Anim","first-page":"135","article-title":"PREPARE: Guidelines for planning animal research and testing","volume":"52","author":"SmithAJ","year":"2018","unstructured":"SmithAJ, CluttonRE, LilleyE, HansenKEA, BrattelidT. 2018. PREPARE: Guidelines for planning animal research and testing. Lab Anim 52:135\u2013141. https:\/\/doi.org\/10.1177\/0023677217724823."},{"key":"bib67","series-title":"Proc Natl Acad Sci USA","first-page":"16731","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"SokolH","year":"2008","unstructured":"SokolH, PigneurB, WatterlotL, LakhdariO, Bermudez-HumaranLG, GratadouxJJ, BlugeonS. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105:16731\u201316736. https:\/\/doi.org\/10.1073\/pnas.0804812105."},{"key":"bib68","series-title":"Nat Rev Microbiol","first-page":"630","article-title":"The resilience of the intestinal microbiota influences health and disease","volume":"15","author":"SommerF","year":"2017","unstructured":"SommerF, AndersonJM, BhartiR, RaesJ, RosenstielP. 2017. The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol 15:630\u2013638. https:\/\/doi.org\/10.1038\/nrmicro.2017.58."},{"key":"bib69","series-title":"J Med Microbiol","first-page":"201","article-title":"Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model","volume":"65","author":"Souza\u00c9L","year":"2016","unstructured":"Souza\u00c9L, ElianSD, PaulaLM, GarciaCC, VieiraAT, TeixeiraMM, ArantesRM, NicoliJR, MartinsFS. 2016. Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model. J Med Microbiol 65:201\u2013210. https:\/\/doi.org\/10.1099\/jmm.0.000222."},{"key":"bib70","series-title":"Nature","first-page":"583","article-title":"Temporal development of the gut microbiome in early childhood from the TEDDY study","volume":"562","author":"StewartCJ","year":"2018","unstructured":"StewartCJ, AjamiNJ, O\u2019BrienJL, HutchinsonDS, SmithDP, WongMC, RossMC. 2018. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562:583\u2013588. https:\/\/doi.org\/10.1038\/s41586-018-0617-x."},{"key":"bib71","series-title":"Arthritis Rheumatol","first-page":"114","article-title":"Brief report: Dialister as a microbial marker of disease activity in spondyloarthritis","volume":"69","author":"TitoRY","year":"2017","unstructured":"TitoRY, CypersH, JoossensM, VarkasG, Van PraetL, GlorieusE, Van den BoschF, De VosM, RaesJ, ElewautD. 2017. Brief report: Dialister as a microbial marker of disease activity in spondyloarthritis. Arthritis Rheumatol 69:114\u2013121. https:\/\/doi.org\/10.1002\/art.39802."},{"key":"bib72","series-title":"Gut","first-page":"42","article-title":"Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice","volume":"69","author":"TorresJ","year":"2020","unstructured":"TorresJ, HuJ, SekiA, EiseleC, NairN, HuangR, TarassishinL. 2020. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. Gut 69:42\u201351. https:\/\/doi.org\/10.1136\/gutjnl-2018-317855."},{"key":"bib73","series-title":"Cell","first-page":"842","article-title":"Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans","volume":"165","author":"VatanenT","year":"2016","unstructured":"VatanenT, KosticAD, d\u2019HennezelE, SiljanderH, FranzosaEA, YassourM, KoldeR. 2016. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165:842\u2013853. https:\/\/doi.org\/10.1016\/j.cell.2016.04.007."},{"key":"bib74","series-title":"Nutrients","first-page":"1565","article-title":"Dietary factors and modulation of bacteria strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A systematic review","volume":"11","author":"VerhoogS","year":"2019","unstructured":"VerhoogS, TaneriPE, Roa DiazZM, Marques-VidalP, TroupJP, BallyL, FrancoOH, GlisicM, MukaT. 2019. Dietary factors and modulation of bacteria strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A systematic review. Nutrients 11:1565. https:\/\/doi.org\/10.3390\/nu11071565."},{"key":"bib75","series-title":"Sci Rep","first-page":"13473","article-title":"Increased abundance of proteobacteria in aggressive Crohn\u2019s disease seven years after diagnosis","volume":"9","author":"Vester-AndersenMK","year":"2019","unstructured":"Vester-AndersenMK, Mirsepasi-LauridsenHC, ProsbergMV, MortensenCO, TragerC, SkovsenK, ThorkilgaardT. 2019. Increased abundance of proteobacteria in aggressive Crohn\u2019s disease seven years after diagnosis. Sci Rep 9:13473. https:\/\/doi.org\/10.1038\/s41598-019-49833-3."},{"key":"bib76","series-title":"BMC Microbiol","first-page":"7","article-title":"High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease","volume":"11","author":"WalkerAW","year":"2011","unstructured":"WalkerAW, SandersonJD, ChurcherC, ParkesGC, HudspithBN, RaymentN, BrostoffJ, ParkhillJ, DouganG, PetrovskaL. 2011. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 11:7. https:\/\/doi.org\/10.1186\/1471-2180-11-7."},{"key":"bib77","series-title":"Gut","first-page":"29","article-title":"A simple clinical colitis activity index","volume":"43","author":"WalmsleyRS","year":"1998","unstructured":"WalmsleyRS, AyresRC, PounderRE, AllanRN. 1998. A simple clinical colitis activity index. Gut 43:29\u201332. https:\/\/doi.org\/10.1136\/gut.43.1.29."},{"key":"bib78","series-title":"Gut Microbes","first-page":"234","article-title":"Comparative evaluation of establishing a human gut microbial community within rodent models","volume":"3","author":"Wos-OxleyM","year":"2012","unstructured":"Wos-OxleyM, BleichA, OxleyAP, KahlS, JanusLM, SmoczekA, NahrstedtH. 2012. Comparative evaluation of establishing a human gut microbial community within rodent models. Gut Microbes 3:234\u2013249. https:\/\/doi.org\/10.4161\/gmic.19934."},{"key":"bib79","series-title":"BMC Microbiol","first-page":"206","article-title":"Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags","volume":"10","author":"WuGD","year":"2010","unstructured":"WuGD, LewisJD, HoffmannC, ChenYY, KnightR, BittingerK, HwangJ. 2010. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags. BMC Microbiol 10:206. https:\/\/doi.org\/10.1186\/1471-2180-10-206."},{"key":"bib80","series-title":"Front Microbiol","first-page":"1274","article-title":"5-Aminosalicylic acid alters the gut bacterial microbiota in patients with ulcerative colitis","volume":"9","author":"XuJ","year":"2018","unstructured":"XuJ, ChenN, WuZ, SongY, ZhangY, WuN, ZhangF, RenX, LiuY. 2018. 5-Aminosalicylic acid alters the gut bacterial microbiota in patients with ulcerative colitis. Front Microbiol 9:1274. https:\/\/doi.org\/10.3389\/fmicb.2018.01274."},{"key":"bib81","series-title":"Mucosal Immunol","first-page":"1348","article-title":"Cesarean section increases sensitivity to oxazolone-induced colitis in C57BL\/6 mice","volume":"12","author":"ZachariassenLF","year":"2019","unstructured":"ZachariassenLF, HansenAK, KrychL, NielsenDS, HolmTL, TougaardP, HansenCHF. 2019. Cesarean section increases sensitivity to oxazolone-induced colitis in C57BL\/6 mice. Mucosal Immunol 12:1348\u20131357. https:\/\/doi.org\/10.1038\/s41385-019-0207-8."},{"key":"bib82","series-title":"BioMed Res Int","first-page":"5828959","article-title":"Lower level of bacteroides in the gut microbiota is associated with inflammatory bowel disease: A meta-analysis","volume":"2016","author":"ZhouY","year":"2016","unstructured":"ZhouY, ZhiF. 2016. Lower level of bacteroides in the gut microbiota is associated with inflammatory bowel disease: A meta-analysis. BioMed Res Int 2016:5828959. https:\/\/doi.org\/10.1155\/2016\/5828959."},{"key":"bib83","series-title":"PLoS One","first-page":"e63686","article-title":"Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease","volume":"8","author":"ZitomerskyNL","year":"2013","unstructured":"ZitomerskyNL, AtkinsonBJ, FranklinSW, MitchellPD, SnapperSB, ComstockLE, BousvarosA. 2013. Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One 8:e63686. https:\/\/doi.org\/10.1371\/journal.pone.0063686."}],"container-title":["Comparative Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010023\/74\/2\/article-p55.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010023\/74\/2\/article-p55.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010023\/74\/2\/article-p55.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:35:15Z","timestamp":1734741315000},"score":1,"resource":{"primary":{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010023\/74\/2\/article-p55.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":83,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.30802\/aalas-cm-23-000065","relation":{},"ISSN":["1532-0820"],"issn-type":[{"type":"print","value":"1532-0820"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}